Maria Nachury
university of lille
172 Papers
206 Citations
Maria Nachury is an academic researcher from university of lille. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 90 publications. Previous affiliations of Maria Nachury include University of Franche-Comté.
Chat about Author
Papers
Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis.
Gauthier Pellet,Carmen Stefanescu,Franck Carbonnel,Laurent Peyrin-Biroulet,Xavier Roblin,C. Allimant,Maria Nachury,Stéphane Nancey,Jérôme Filippi,Romain Altwegg,Hedia Brixi,Ginette Fotsing,Laure de Rosamel,Sarah Shili,David Laharie,Groupe d’Étude Thérapeutique des Affections Inflammatoires du Tube Digestif +15 more
TL;DR: In a retrospective analysis of 39 patients with an active steroid‐refractory UC, initial treatment with a calcineurin inhibitor in combination with vedolizumab allowed more than two thirds of patients to avoid colectomy.
73
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial.
Gilles Bommelaer,David Laharie,Stéphane Nancey,Xavier Hébuterne,Xavier Roblin,Maria Nachury,Laurent Peyrin-Biroulet,Mathurin Fumery,Damien Richard,Bruno Pereira,Marion Goutte,Anthony Buisson,Dilek Coban,Marie Dodel,Felix Goutorbe,C. Allimant,Maud Reymond,Michel Dapoigny,Olivier Rouquette,Emilie Vazeille,Florian Poullenot,Pauline Rivière,Gilles Boschetti,Jérôme Filippi,Emilie Del Tedesco,Pauline Veyrard,Benjamin Pariente,Pauline Wils,Camille Zallot,Clara Yzet,Franck Brazier +30 more
TL;DR: In a double-blind randomized controlled trial of patients who underwent surgery for CD and received thiopurine treatment, curcumin was no more effective than placebo in preventing CD recurrence.
45
Cyclosporin Versus Infliximab in Severe Acute Ulcerative Colitis Refractory to Intravenous Steroids: A Randomized Trial
David Laharie,Arnaud Bourreille,Julien Branche,Matthieu Allez,Yoram Bouhnik,Jérôme Filippi,Frank Zerbib,Maria Nachury,Guillaume Savoye,Jacques Moreau,Jean-Charles Delchier,Elena Ricart,Jacques Cosnes,Antonio Roman,Olivier Dewit,Franck Carbonnel,Benoit Coffin,Gert A. Van Assche,Maria Esteve,Martti Färkkilä,Javier P. Gisbert,Gilles Bommelaer,Philippe Marteau,Stéphane Nahon,Martine De Vos,Denis Franchimont,Jean-Yves Mary,Jean-Frederic Colombel,Marc Lémann +28 more
43
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial
Julián Panés,Gerd Bouma,Marc Ferrante,Torsten Kucharzik,Maria Nachury,F. de la Portilla de Juan,Walter Reinisch,Francesco Selvaggi,Jörg Tschmelitsch,Neil R Brett,Martin Ladouceur,M. Binek,Gary Hantsbarger,Sarah Campbell-Hill,C. Karki,Christianne J. Buskens +15 more
TL;DR: Real-world follow-up of patients from the ADMIRE-CD trial indicates that clinical remission of complex perianal fistulas can be sustained in the long term irrespective of whether it is achieved through darvadstrocel administration or maintenance treatment regimens and confirms a favorable long-term safety profile of darVad Strocel.
•Journal Article
Drug-concentration versus symptom-driven dose adaptation of Infliximab in patients with active Crohn's disease: a prospective, randomised, multicentre trial (Tailorix)
G. D'Haens,Severine Vermeire,Guy Lambrecht,F Baert,Peter Bossuyt,Maria Nachury,A. Buisson,Yoram Bouhnik,Jérôme Filippi,J Vande Woude,P Van Hootegem,Jacques Moreau,Edouard Louis,Denis Franchimont,M. De Vos,Fazia Mana,L Peyrin-Biroulet,Hedia Brixi,Mathieu Allez,Philip Caenepeel,Alexandre Aubourg,Bas Oldenburg,Marie J. Pierik,Ann Gils,Sylvie Chevret,D. Laharie +25 more
37